Assessment of myocardial viability with technetium-99m isonitrile and thallium-201. Results of a Spanish multicenter trial;Valoracion de la viabilidad miocardica mediante tecnecio-99m isonitrilo y talio-201. Resultados del protocolo multicentrico espanol

Revista Espanola de Cardiologia

Volumn 50, Issue 5, 1997, Pages 320-330

  Castell Conesa, J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

myocardial viability; technetium 99m methoxy isobutyl isonitrile; thallium 201

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201; DIAGNOSTIC AGENT; NITRILE; TECHNETIUM COMPLEX; TECHNETIUM TC 99M HEXAKIS(TERT-BUTYLISONITRILE); TERT BUTYL ISOCYANIDE TECHNETIUM TC 99M; THALLIUM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE CONTRACTILITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; HEART; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; SCINTISCANNING; SPAIN;

CORONARY DISEASE; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; NITRILES; ORGANOTECHNETIUM COMPOUNDS; SPAIN; THALLIUM RADIOISOTOPES;

EID: 0030916134     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(97)73229-9     Document Type: Article

References (46)

1. Braunwald E, Rutheford JD. Reversible ischemic left ventricular dysfunction: evidence for the «hibernating myocardium». J Am Coll Cardiol 1986; 8: 1.467-1.470.
2. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117: 211-221.
3. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66: 1.146-1.149.
4. Bolli R. Myocardial «stunning» in man. Circulation 1992; 86: 1.671-1.691.
5. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994; 90: 2.687-2.694.
6. Brunken R, Tillisch J, Schwaiger M, Child JS, Marshall R, Maldenkern M et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986; 73: 951-963.
7. Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 1987; 10: 557-567.
8. Tillisch J, Brunken R, Marshall R, Schwaiger M, Maldenkern M, Pheps M et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-888.
9. Schwaiger M, Hicks R. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991; 32: 565-578.
10. Henes CG, Bergmann SR, Walsh MN, Sobel BE, Geltman EM. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and Carbon-11 acetate. J Nucl Med 1989; 30: 1.489-1.499.
11. Marshall RC, Tillisch JH, Phelps ME, Huang SC, Carson R, Henze E et al. Identification and differentiation of resting myocardial ischemia in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and 13N-ammonia. Circulation 1983; 67: 766-778.
12. Tamaki N, Yonekura Y, Yamashita K, Saji H, Magata Y, Senda M et al. Positron Emission Tomography using Fluorine-18 Deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989; 64: 865-890.
13. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-146.
14. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary atery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-Fluorodeoxyglucose. Circulation 1991; 83: 26-37.
15. Dilsizian V, Freedman NMT, Bacharach SL, Perrone-Filardi P, Bonow RO. Regional thallium uptake in irreversible defects. Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. Circulation 1992; 85: 627-634.
16. 99mTc-sestamibi with thallium-201 reeinjection and (18F)fluorodeoxyglucose. Circulation 1994; 89: 578-587.
17. Iskandrian AS, Hakki A, Kane SA, Goel IP, Mundth ED, Hakki A et al. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting. Am J Cardiol 1983; 51: 1.312-1.316.
18. Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med 1992; 33: 1.925-1.930.
19. Rocco TP, Dilsizian V, Strauss HW, Boucher CA. Technetium-99m isonitrile myocardial uptake at rest II. Relation to clinical markers of potential viability. J Am Coll Cardiol 1989; 14: 1.678-1.684.
20. . Kiat H, Berman DS, Maddahi J, Yang DL, Van Train K, Rozanski A et al. Late reversibility of tomographic miocardial thallium201 defects: an accurate predictor of myocardial viability. J Am Coll Cardiol 1988; 12: 1.456-1.463.
21. Iskandnan AS. Myocardial viability: unresolved issues. J Nucl Med 1996; 37: 794-797.
22. Inglese E, Barabrilla M, Dondi M, Pieri PL, Bisi G. Cannizzaro G et al. Assessment of myocardial viability after Thallium-201 reinjection or rest-resdistribution imaging: a multicenter study. J Nucl Med 1995; 36: 555-563.
23. 201T1 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87: 1.630-1.641.
24. Dilsizian V, Perrone-Filardi P, Arrighi JA, Bacharach SL. Quyyumi AA, Freedman NM et al. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography. Circulation 1993; 88: 941-952.
25. Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y. Restinjected tallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991; 32: 1.718-1.724.
26. Rocco TP, Dilsizian V, McKusick KA, Fishman AJ, Boucher CA, Strauss HW. Comparison of thallium redistribution with rest «reinjection» imaging for the detection of viable myocardium. Am J Cardiol 1990; 66: 158-163.
27. Dilsizian V, Rocco TP, Strauss HW, Boucher CA. Technetium99m isonitrile myocardial uptake at rest. I. Relation to severity of coronary artery stenosis. J Am Coll Cardiol 1989; 14: 1.678-1.684.
28. 99mTc-Sestamibi. Circulation 1994; 89: 2.552-2.561.
29. Pierard LA, De Landsheere C, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infaction after thrombolytic therapy: comparison with possitron emission tomography. J Am Coll Cardiol 1990; 15: 1.021-1.031.
30. Nesto RW, Cohn LH, Collins JJ, Wynne J, Holman L, Cohn PF. Inotropic contractile reserve: a useful predictor of increased 5 year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am J Cardiol 1982; 50: 39-44.
31. Perrone-Filardi P, Bacharach SL, Dilsizian V, Maurea S, Martin-Neto JA, Arrighi JA et al. Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 1992; 20: 161-168.
32. Dilsizian V, Bonow RO, Cannon RO, Tracy CM, Vitale DF, McIntosh CL et al. The effect of coronary bypass grafting on left ventricular systolic function at rest: evidence for preoperative subclinical myocardial ischemia. Am J Cardiol 1988; 61: 1.248-1.254.
33. Eitzman D, Al-Aquar Z, Kanter HL, Van Dahl J, Kirsh M, Deeb GM et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992; 20: 559-565.
34. DiCarli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995; 92: 3.436-3.444.
35. Chaitman BR, Jaffe AS. What is the true perioperative myocardial infarction rate? Does anyone know for sure? The need for clarification. Circulation 1995; 91: 1.609-1.610.
36. 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease. Eur J Nucl Med 1992; 19: 334-342.
37. Altehoefer C, Von Dahl J, Biedermann M, Uebis R, Beilin I, Sheehan F et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994; 35: 569-574.
38. Afridi I, Kleinman NS, Raizer AE, Zoghbi WA. Dobutamine echocardiography un myocardial hibernation: optimal dose and accuracy in predigting recovery of ventricular function after coronary angioplasty. Circulation 1995; 91: 663-670.
39. Ghods M, Pancholy S, Cave V, Cassell D, Heo J, Iskandrian AS. Serial changes in left ventricular function after coronary artery bypass: implications in viability assessment. Am Heart J 1995; 129: 20-23.
40. Takeishi Y, Tono-oka I, Kubota I, Ikeda K, Masakane I, Chiba J et al. Functional recovery of hibernating myocardium after coronary bypass surgery: does it coincide with improvement in perfusion? Am Heart J 1991; 122: 665-670.
41. Elefteriades JA, Tolis G, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993; 22: 1.411-1.417.
42. . Altehoefer C, Vom Dhal, Buell U, Uebis R, Kleinhans E, Hanrath P. Comparison of thallium-201 single-photon emission tomography after rest injection and fluorodeoxygiucose positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery deisease. Eur J Nucl Med 1994; 21: 37-45.
43. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutylisonitrile. J Nucl Med 1992; 33: 505-511.
44. Dondi M, Tartagni F, Fallani F, Fanti S, Marengo M, DiTomaso I et al. A comparison of rest sestamibi and rest-redistribution thallium single photon emission tomography: possible implications for myocardial viability detection in infarcted patients. Eur J Nucl Med 1993; 20: 26-31.
45. Sawada SG, Almman KC, Muzik O, Beanlands RS, Wolfe ER, Gross M et al. Positron emission tomography detects evidence of viability in rest Technetium-99m Sestamibi defects. J Am Coll Cardiol 1994; 23: 92-98.
46. 99mTc-Sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study. Circulation 1996; 94: 1.010-1.017.